Gentry T King

5PUBLICATIONS
61CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.

|Dec 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Amy H Huang, Gin Yi Lee, Chuan Angel Lu

|Mar 06, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Lakshmi Rajdev, Gentry G King, Christopher H Lieu

|Dec 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

Rachna T Shroff, Gentry King, Sarah Colby

|Jul 16, 2021
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma.

Gentry King, Milind Javle

Pageof 1

Frequent Collaborators

2 joint publications

E Gabriela Chiorean

2 joint publications

Milind M Javle

2 joint publications

Philip A Philip

1 joint publications

Ronan W Hsieh